NDC 70518-0174-01 - Lisinopril and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-0174
- Requested NDC
- 70518-0174-01
- Package NDCs from labels
- 70518-0174-0, 70518-0174-1, 70518-0174-2, 70518-0174-3, 70518-0174-4, 70518-0174-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-06-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS USP | REMEDYREPACK INC. | 2026-06-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-0174-0 | Lisinopril and Hydrochlorothiazide | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 25 | |
| 70518-0174-1 | Lisinopril and Hydrochlorothiazide | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 25 | |
| 70518-0174-2 | Lisinopril and Hydrochlorothiazide | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 25 | |
| 70518-0174-3 | Lisinopril and Hydrochlorothiazide | 30 in 1 BLISTER PACK | TABLET | 30 | 25 | |
| 70518-0174-4 | Lisinopril and Hydrochlorothiazide | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 25 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-0174 | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [REMEDYREPACK INC.] | 21 | Current NDC, Legacy NDC, 5 package rows | 20250424_408e797a-2cf3-4ee6-9f9b-179a8cf3d799.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lisinopril | LISINOPRIL | NuCare Pharmaceuticals,Inc. | ab9bc1b4-60cc-76ea-e053-2995a90ac203 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | NuCare Pharmaceuticals,Inc. | af74c331-7402-408c-e053-2a95a90a1043 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 197886 E7199S1YWR 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | NuCare Pharmaceuticals,Inc. | b2e8b3bb-0ab5-ffd7-e053-2995a90aa2b6 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 197885 E7199S1YWR 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | NuCare Pharmaceuticals,Inc. | b4c9abf7-a2c6-7042-e053-2a95a90a7653 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 197887 E7199S1YWR 0J48LPH2TH |
| Lisinopril and hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | NuCarePharmaceuticals, Inc. | 4fbf31a1-037b-31a2-e054-00144ff88e88 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 197885 E7199S1YWR 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 7c214ebf-e0ed-6538-e053-2991aa0a8079 | 2024-07-16 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals, Inc. | 4925a3ad-63bd-108a-e054-00144ff8d46c | 2024-07-15 | Boxed warning, Warnings, Adverse reactions | ANDA077912 197887 E7199S1YWR 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | NuCare Pharmaceuticals,Inc. | 5a1c5b04-b78c-c057-e053-2991aa0aa916 | 2024-07-15 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| LISINOPRIL | LISINOPRIL | NuCare Pharmaceuticals,Inc. | 5786b8d9-3818-66a5-e053-2991aa0a7025 | 2024-07-15 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals, Inc. | 53fe1730-a803-26b2-e054-00144ff88e88 | 2024-07-09 | Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | d57188d2-c3af-4879-bf17-f37eaf733aca | 2024-07-09 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | NuCare Pharmaceuticals, Inc. | 51c80515-b26d-5776-e054-00144ff8d46c | 2024-07-08 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | af44b2b0-1204-43c9-8ec1-d081d35b8f2b | 2024-06-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | e8a9dcaa-04e3-4f4e-a53d-42903e3da2d4 | 2024-06-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | e31bd548-29ae-419a-831a-80ebb26e042f | 2024-06-26 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 01f1f478-5493-439f-9b99-f4f82023781c | 2024-06-26 | Warnings, Adverse reactions | 0J48LPH2TH |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 681dfb5c-fc5c-427e-81f6-4b4e934978a2 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | a111cb8f-a100-a05d-e053-2995a90a020c | 2024-06-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril | LISINOPRIL | NuCare Pharmaceuticals,Inc. | 90a589a9-acc2-bfbe-e053-2995a90a0bd2 | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| LISINOPRIL | LISINOPRIL | NuCare Pharmaceuticals,Inc. | 9148529f-6278-e507-e053-2995a90aa4cf | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.